These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3407598)

  • 1. Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure.
    Colardyn FA; Vandenbogaerde JF
    Am J Cardiol; 1988 Aug; 62(5):68C-72C. PubMed ID: 3407598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical development of dopexamine hydrochloride (Dopacard) and an overview of its hemodynamic effects.
    Foulds RA
    Am J Cardiol; 1988 Aug; 62(5):41C-45C. PubMed ID: 3044060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic comparison of dopexamine hydrochloride and dopamine in ischemic left ventricular dysfunction.
    Jackson NC; Taylor SH; Frais MA
    Am J Cardiol; 1988 Aug; 62(5):73C-77C. PubMed ID: 2457305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
    Leier CV; Binkley PF; Carpenter J; Randolph PH; Unverferth DV
    Am J Cardiol; 1988 Jul; 62(1):94-9. PubMed ID: 2898209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
    Santman FW
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
    Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI
    Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
    Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
    Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
    Jaski BE; Peters C
    Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of dopexamine hydrochloride infusions of 48 to 72 hours' duration for severe congestive heart failure.
    Gollub SB; Emmot WW; Johnson DE; Sights KA; Wilson DB; Vacek JL; Hassanein K
    Am J Cardiol; 1988 Aug; 62(5):83C-88C. PubMed ID: 3407599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal effects of an infusion of dopexamine hydrochloride in horses anesthetized with halothane.
    Young LE; Blissitt KJ; Clutton RE; Molony V
    Am J Vet Res; 1997 May; 58(5):516-23. PubMed ID: 9140561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
    Baumann G; Felix SB; Filcek SA
    Am J Cardiol; 1990 Mar; 65(11):748-54. PubMed ID: 1969223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
    Svenson G; Strandberg LE; Lindvall B; Erhardt L
    Br Heart J; 1988 Dec; 60(6):489-96. PubMed ID: 3224052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study.
    Gollub SB; Elkayam U; Young JB; Miller LW; Haffey KA
    J Am Coll Cardiol; 1991 Aug; 18(2):383-90. PubMed ID: 1677368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
    Tan LB; Littler WA; Murray RG
    Int J Cardiol; 1991 Feb; 30(2):203-8. PubMed ID: 2010243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
    De Marco T; Kwasman M; Lau D; Chatterjee K
    Am J Cardiol; 1988 Aug; 62(5):57C-62C. PubMed ID: 3407596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopexamine hydrochloride after coronary artery bypass grafting.
    van der Starre PJ; Rosseel PM
    Am J Cardiol; 1988 Aug; 62(5):78C-82C. PubMed ID: 3261535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure.
    Svensson G; Sjögren A; Erhardt L
    Eur Heart J; 1986 Aug; 7(8):697-703. PubMed ID: 2876894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial haemodynamic effects of intravenous dopexamine in patients with low-output heart failure.
    Tan LB; Littler WA; Murray RG
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):280-6. PubMed ID: 2444775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.